These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25736821)

  • 41. Genomic SELEX search for target promoters under the control of the PhoQP-RstBA signal relay cascade.
    Ogasawara H; Hasegawa A; Kanda E; Miki T; Yamamoto K; Ishihama A
    J Bacteriol; 2007 Jul; 189(13):4791-9. PubMed ID: 17468243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficient and precise construction of markerless manipulations in the Bacillus subtilis genome.
    Yu H; Yan X; Shen W; Shen Y; Zhang J; Li S
    J Microbiol Biotechnol; 2010 Jan; 20(1):45-53. PubMed ID: 20134232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High isoprenoid flux Escherichia coli as a host for carotenoids production.
    Suh W
    Methods Mol Biol; 2012; 834():49-62. PubMed ID: 22144352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening of the osmotic pressure-inducible promoter regions from the whole genome of Escherichia coli by using a novel cloning method.
    Wang Z; Jin L; Wegrzyn G; Wegrzyn A
    Biotechnol Lett; 2008 Apr; 30(4):707-11. PubMed ID: 17985080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A simple method to introduce marker-free genetic modifications into the chromosome of naturally nontransformable Bacillus amyloliquefaciens strains.
    Zakataeva NP; Nikitina OV; Gronskiy SV; Romanenkov DV; Livshits VA
    Appl Microbiol Biotechnol; 2010 Jan; 85(4):1201-9. PubMed ID: 19820923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli.
    Xu P; Vansiri A; Bhan N; Koffas MA
    ACS Synth Biol; 2012 Jul; 1(7):256-66. PubMed ID: 23651248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Control of the ferric citrate transport system of Escherichia coli: mutations in region 2.1 of the FecI extracytoplasmic-function sigma factor suppress mutations in the FecR transmembrane regulatory protein.
    Stiefel A; Mahren S; Ochs M; Schindler PT; Enz S; Braun V
    J Bacteriol; 2001 Jan; 183(1):162-70. PubMed ID: 11114913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell Break: How Cell-Free Biology Is Finally Putting the Engineering Back in Bioengineering.
    Fischer S
    IEEE Pulse; 2016; 7(2):13-6. PubMed ID: 26978845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and optimization of Lysis gene E as a counter-selection marker with high stringency.
    Chen W; Chen R; He L; Wu X
    Biotechnol J; 2022 Aug; 17(8):e2100423. PubMed ID: 35373931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficient Bacterial Genome Engineering throughout the Central Dogma Using the Dual-Selection Marker
    Bayer CN; Sepulchro AGV; Rennig M; Nørholm MHH
    ACS Synth Biol; 2022 Oct; 11(10):3440-3450. PubMed ID: 36206506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complete genome sequencing revealed novel genetic contexts of the mcr-1 gene in Escherichia coli strains.
    Yu CY; Ang GY; Chong TM; Chin PS; Ngeow YF; Yin WF; Chan KG
    J Antimicrob Chemother; 2017 Apr; 72(4):1253-1255. PubMed ID: 28031273
    [No Abstract]   [Full Text] [Related]  

  • 52. Extension of Genetic Marker List Using Unnatural Amino Acid System: An Efficient Genomic Modification Strategy in
    Xu X; Zhong H; Liu W; Tao Y
    Front Bioeng Biotechnol; 2020; 8():145. PubMed ID: 32411679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reporting off-target effects of recombinant engineering using the pORTMAGE system.
    Sanders BR; Townsend SE; Ford ML; Graves JL; Thomas MD
    J Microbiol Methods; 2023 Jan; 204():106627. PubMed ID: 36436701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parallel mapping of genotypes to phenotypes contributing to overall biological fitness.
    Gall S; Lynch MD; Sandoval NR; Gill RT
    Metab Eng; 2008 Nov; 10(6):382-93. PubMed ID: 18789396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The red recombination system and its application to gene knock-out in microorganism].
    Hu K; Shi ZX; Sai DJ; Huang LY
    Yi Chuan; 2003 Sep; 25(5):628-32. PubMed ID: 15639946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chiral supernanostructures for ultrasensitive endonuclease analysis.
    Hao C; Kuang H; Xu L; Liu L; Ma W; Wang L; Xu C
    J Mater Chem B; 2013 Nov; 1(41):5539-5542. PubMed ID: 32261177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.
    Blair JM; Bavro VN; Ricci V; Modi N; Cacciotto P; Kleinekathӧfer U; Ruggerone P; Vargiu AV; Baylay AJ; Smith HE; Brandon Y; Galloway D; Piddock LJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3511-6. PubMed ID: 25737552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lambda red mediated gap repair utilizes a novel replicative intermediate in Escherichia coli.
    Reddy TR; Fevat LM; Munson SE; Stewart AF; Cowley SM
    PLoS One; 2015; 10(3):e0120681. PubMed ID: 25803509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiplexed tracking of combinatorial genomic mutations in engineered cell populations.
    Zeitoun RI; Garst AD; Degen GD; Pines G; Mansell TJ; Glebes TY; Boyle NR; Gill RT
    Nat Biotechnol; 2015 Jun; 33(6):631-7. PubMed ID: 25798935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autonomous production of 1,4-butanediol via a de novo biosynthesis pathway in engineered Escherichia coli.
    Liu H; Lu T
    Metab Eng; 2015 May; 29():135-141. PubMed ID: 25796335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.